Table IV.
Correlation of PTEN expression with 3-year survival.
| PTEN expression profile | HR (95% CI) | P-value | Median survival time (months) | Survival rate (%) |
|---|---|---|---|---|
| Cytoplasmic | ||||
| Negative | 0.697 (0.432–1.124) | 0.149 | 36 | 57 |
| Positive | 28 | 46 | ||
| Nuclear | ||||
| Negative | 1.206 (0.716–2.031) | 0.378 | 36 | 52 |
| Positive | 36 | 55 | ||
| Total | ||||
| Negative | 0.827 (0.522–1.310) | 0.520 | 36 | 57 |
| Positive | 35 | 49 | ||
| Total PTEN expression relative to adjacent non-neoplastic tissue | ||||
| Downregulated | 0.800 (0.480–1.335) | 0.421 | 36 | 55 |
| Not downregulated | 28 | 48 |
Cox regression model was used to investigate the correlation of PTEN expression with 3-year survival. HR, hazard ratio; CI, confidence interval.